Saved in:
| Main Authors: | He, Qijia, Gao, Fei, Dukes, Oliver, Delany-Moretlwe, Sinead, Zhang, Bo |
|---|---|
| Format: | Preprint |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2304.03476 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
A comparison of methods for estimating the average treatment effect on the treated for externally controlled trials
by: Wang, Huan, et al.
Published: (2024)
by: Wang, Huan, et al.
Published: (2024)
On estimands in target trial emulation
by: Gervasoni, Edoardo Efrem, et al.
Published: (2026)
by: Gervasoni, Edoardo Efrem, et al.
Published: (2026)
Dealing with positivity violations in mediation analysis via weighted controlled effects, with application to assessing immune correlates of protection in antigen-experienced participants
by: He, Qijia, et al.
Published: (2026)
by: He, Qijia, et al.
Published: (2026)
Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
by: Zhao, Pan, et al.
Published: (2026)
by: Zhao, Pan, et al.
Published: (2026)
Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial
by: Wang, Guanbo, et al.
Published: (2022)
by: Wang, Guanbo, et al.
Published: (2022)
Treatment-control comparisons in platform trials including non-concurrent controls
by: Roig, Marta Bofill, et al.
Published: (2024)
by: Roig, Marta Bofill, et al.
Published: (2024)
Evaluating the performance of Bayesian cumulative logistic models in randomised controlled trials: a simulation study
by: Selman, Chris J., et al.
Published: (2025)
by: Selman, Chris J., et al.
Published: (2025)
Improving precision of cumulative incidence estimates in randomized controlled trials with external controls
by: Su, Zehao, et al.
Published: (2025)
by: Su, Zehao, et al.
Published: (2025)
A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
by: Jeffrey D. Sharon, et al.
Published: (2024)
by: Jeffrey D. Sharon, et al.
Published: (2024)
Causal progress with imperfect placebo treatments and outcomes
by: Rohde, Adam, et al.
Published: (2023)
by: Rohde, Adam, et al.
Published: (2023)
Ethical considerations on placebo-controlled vaccine trials in pregnant women
by: Ana Cecilia Amado Xavier de Oliveira
Published: (2023)
by: Ana Cecilia Amado Xavier de Oliveira
Published: (2023)
Robust integration of external control data in randomized trials
by: Karlsson, Rickard, et al.
Published: (2024)
by: Karlsson, Rickard, et al.
Published: (2024)
Using causal diagrams to assess parallel trends in difference-in-differences studies
by: Renson, Audrey, et al.
Published: (2025)
by: Renson, Audrey, et al.
Published: (2025)
Data-driven controlled subgroup selection in clinical trials
by: Müller, Manuel M., et al.
Published: (2025)
by: Müller, Manuel M., et al.
Published: (2025)
On the inclusion of non-concurrent controls in platform trials with an interim analysis
by: Krotka, Pavla, et al.
Published: (2025)
by: Krotka, Pavla, et al.
Published: (2025)
ADDIS-Graphs for online error control with application to platform trials
by: Fischer, Lasse, et al.
Published: (2023)
by: Fischer, Lasse, et al.
Published: (2023)
Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
by: Nathaniel M. Schuster, et al.
Published: (2025)
by: Nathaniel M. Schuster, et al.
Published: (2025)
Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial
by: Luiz Antonio Bastos Camacho
Published: (2005)
by: Luiz Antonio Bastos Camacho
Published: (2005)
Blinded sample size recalculation in randomized controlled trials with analysis of covariance
by: Kanata, Takumi, et al.
Published: (2025)
by: Kanata, Takumi, et al.
Published: (2025)
Family-wise error rate control in clinical trials with overlapping populations
by: Luschei, Remi, et al.
Published: (2025)
by: Luschei, Remi, et al.
Published: (2025)
A Bayesian likely responder approach for the analysis of randomized controlled trials
by: Deng, Annan, et al.
Published: (2025)
by: Deng, Annan, et al.
Published: (2025)
Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
by: Emmanuelle A. D. Schindler, et al.
Published: (2025)
by: Emmanuelle A. D. Schindler, et al.
Published: (2025)
Improving randomized controlled trial analysis via data-adaptive borrowing
by: Gao, Chenyin, et al.
Published: (2023)
by: Gao, Chenyin, et al.
Published: (2023)
Estimating treatment effects with competing intercurrent events in randomized controlled trials
by: Lu, Sizhu, et al.
Published: (2025)
by: Lu, Sizhu, et al.
Published: (2025)
Leveraging external data in the analysis of randomized controlled trials: a comparative analysis
by: Kotecha, Gopal, et al.
Published: (2024)
by: Kotecha, Gopal, et al.
Published: (2024)
Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials: a simulation study
by: Selman, Chris J., et al.
Published: (2025)
by: Selman, Chris J., et al.
Published: (2025)
Comparative efficacy and tolerability of currently approved incretin mimetics: A systematic analysis of placebo‐controlled clinical trials
by: Yu Mi Kang, et al.
Published: (2025)
by: Yu Mi Kang, et al.
Published: (2025)
On the estimation of inclusion probabilities for weighted analyses of nested case control studies
by: López-Nieto-Veitch, Tomeu, et al.
Published: (2026)
by: López-Nieto-Veitch, Tomeu, et al.
Published: (2026)
NCC: An R-package for analysis and simulation of platform trials with non-concurrent controls
by: Krotka, Pavla, et al.
Published: (2023)
by: Krotka, Pavla, et al.
Published: (2023)
Increasing power and robustness in screening trials by testing stored specimens in the control arm
by: Katki, Hormuzd A., et al.
Published: (2024)
by: Katki, Hormuzd A., et al.
Published: (2024)
Doubly robust omnibus sensitivity analysis of externally controlled trials with intercurrent events
by: Gao, Chenyin, et al.
Published: (2025)
by: Gao, Chenyin, et al.
Published: (2025)
Making all pairwise comparisons in multi-arm clinical trials without control treatment
by: Burnett, Thomas, et al.
Published: (2024)
by: Burnett, Thomas, et al.
Published: (2024)
Jointly modeling multiple endpoints for efficient treatment effect estimation in randomized controlled trials
by: Wolf, Jack M., et al.
Published: (2025)
by: Wolf, Jack M., et al.
Published: (2025)
On the uncertainty from the first-stage estimation of prognostic covariate adjustment in randomized controlled trials
by: Seya, Nodoka, et al.
Published: (2026)
by: Seya, Nodoka, et al.
Published: (2026)
Trick or treat? It's time to rethink the role of placebo in clinical trial
by: Ping‐Tao Tseng, et al.
Published: (2024)
by: Ping‐Tao Tseng, et al.
Published: (2024)
Doubly protected estimation for survival outcomes utilizing external controls for randomized clinical trials
by: Gao, Chenyin, et al.
Published: (2024)
by: Gao, Chenyin, et al.
Published: (2024)
Dynamic borrowing from historical controls via the synthetic prior with covariates in randomized clinical trials
by: Schwartz, Daniel E., et al.
Published: (2024)
by: Schwartz, Daniel E., et al.
Published: (2024)
Statistical modeling to adjust for time trends in adaptive platform trials utilizing non-concurrent controls
by: Krotka, Pavla, et al.
Published: (2024)
by: Krotka, Pavla, et al.
Published: (2024)
Identification and estimation of causal effects using non-concurrent controls in platform trials
by: Santacatterina, Michele, et al.
Published: (2024)
by: Santacatterina, Michele, et al.
Published: (2024)
Subgroup analysis methods for time-to-event outcomes in heterogeneous randomized controlled trials
by: Perrin, Valentine, et al.
Published: (2024)
by: Perrin, Valentine, et al.
Published: (2024)
Similar Items
-
A comparison of methods for estimating the average treatment effect on the treated for externally controlled trials
by: Wang, Huan, et al.
Published: (2024) -
On estimands in target trial emulation
by: Gervasoni, Edoardo Efrem, et al.
Published: (2026) -
Dealing with positivity violations in mediation analysis via weighted controlled effects, with application to assessing immune correlates of protection in antigen-experienced participants
by: He, Qijia, et al.
Published: (2026) -
Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
by: Zhao, Pan, et al.
Published: (2026) -
Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial
by: Wang, Guanbo, et al.
Published: (2022)